We are live on ! Find out more
BIIB icon

Biogen
BIIB

1,031 hedge funds and large institutions have $34.2B invested in Biogen in 2022 Q4 according to their latest regulatory filings, with 159 funds opening new positions, 325 increasing their positions, 362 reducing their positions, and 96 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more first-time investments, than exits

New positions opened: 159 | Existing positions closed: 96

14% more funds holding in top 10

Funds holding in top 10: 22 → 25 (+3)

5% more funds holding

Funds holding: 986 → 1,031 (+45)

1.43% more ownership

Funds ownership: 85.29% → 86.72% (+1.4%)

4% more capital invested

Capital invested by funds: $32.8B → $34.2B (+$1.4B)

10% less repeat investments, than reductions

Existing positions increased: 325 | Existing positions reduced: 362

14% less call options, than puts

Call options by funds: $1.29B | Put options by funds: $1.51B

Holders
1,031
Holders Change
+45
Holders Change %
+4.56%
% of All Funds
16.57%
Holding in Top 10
25
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+13.64%
% of All Funds
0.4%
New
159
Increased
325
Reduced
362
Closed
96
Calls
$1.29B
Puts
$1.51B
Net Calls
-$216M
Net Calls Change
-$369M

Top Buyers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
+$309M
2
BlackRock
BlackRock
New York
+$117M
3
DTC
Deep Track Capital
Connecticut
+$84.7M
4
FCM
Farallon Capital Management
California
+$81.1M
5
Barclays
Barclays
United Kingdom
+$81M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$162M
2
APM
Avidity Partners Management
Texas
-$160M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$128M
4
Goldman Sachs
Goldman Sachs
New York
-$118M
5
RCM
RA Capital Management
Massachusetts
-$114M
Name Holding Trade Value Shares
Change 		Change in
Stake
NC
1001
NewSquare Capital
Pennsylvania
$3.6K +$2.54K +9 +225%
TC
1002
Truvestments Capital
Florida
$3.32K – – –
SBL
1003
Sargent Bickham Lagudis
Colorado
$3.05K -$5.65K -20 -65%
CCA
1004
Column Capital Advisors
Indiana
$3.05K – – –
CAL
1005
Capital Advisors Ltd
Ohio
$3K +$46.9K +166 +1,844%
BWM
1006
BerganKDV Wealth Management
Minnesota
$2.77K -$565 -2 -17%
LF
1007
Lee Financial
Texas
$2.77K – – –
MWM
1008
Mascoma Wealth Management
New Hampshire
$2.49K – – –
APC
1009
Aspire Private Capital
North Carolina
$2.21K – – –
FP
1010
Financial Perspectives
Minnesota
$2.21K – – –
FGAM
1011
Financial Gravity Asset Management
Texas
$2K -$827K -2,927 -91%
TFGT
1012
TS Financial Group (TSFG)
Illinois
$2K – – –
Jones Financial Companies
1013
Jones Financial Companies
Missouri
$2K +$1.7K +6 New
PPC
1014
Park Place Capital
Alabama
$2K +$1.98K +7 New
ARS
1015
Adirondack Retirement Specialists
New York
$1.94K – – –
RTL
1016
Red Tortoise LLC
Georgia
$1.94K +$1.98K +7 New
AAP
1017
Arax Advisory Partners
Colorado
$1.39K – – –
EWM
1018
Evermay Wealth Management
Virginia
$1.39K – – –
LFA
1019
Legend Financial Advisors
Pennsylvania
$1.39K – – –
CTA
1020
Colonial Trust Advisors
South Carolina
$1.39K +$1.41K +5 New
TWD
1021
True Wealth Design
Ohio
$1.11K +$1.13K +4 New
ECM
1022
Everence Capital Management
Indiana
$1.09K +$25.4K +90 +2%
PP
1023
PrairieView Partners
Minnesota
$1K – – –
TFM
1024
TFC Financial Management
Massachusetts
$831 – – –
PI
1025
PEAK6 Investments
Illinois
$734 +$282 +1 +50%
39 40
41
42 43

BIIB Hedge Fund Activity: Q4 2022 in Review

1,031 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q4 2022, worth a combined $34.2B — up 4.3% from $32.8B a quarter earlier.

Buyers outnumbered sellers: 159 funds opened new BIIB positions and 96 closed out — a net gain of 63 holders — while 325 added to existing stakes and 362 trimmed.

The largest buyer was Marshall Wace, adding an estimated $309M. The largest seller was Millennium Management, cutting an estimated $162M.

  • 1,031 institutional investors held Biogen (BIIB) as of Q4 2022, up from 986 in Q3 2022.
  • Funds reported $34.2B of Biogen stock for Q4 2022, up 4.3% quarter-over-quarter.
  • 159 funds opened new Biogen positions in Q4 2022 and 96 closed out, a net change of +63 holders.
  • The largest Biogen buyer in Q4 2022 was Marshall Wace, an estimated $309M added.
  • The largest Biogen seller in Q4 2022 was Millennium Management, an estimated $162M sold.

Based on aggregated 13F filings for Q4 2022.